Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORA | P35398 | 4/20 | 0.56 |
| ▸ | RORC | P51449 | 4/20 | 0.56 |
| ▸ | RORB | Q92753 | 4/20 | 0.56 |
| ▸ | PGR | P06401 | 3/20 | 0.56 |
| ▸ | DRD2 | P14416 | 3/20 | 0.45 |
| ▸ | DRD3 | P35462 | 3/20 | 0.45 |
| ▸ | SCARB1 | Q8WTV0 | 2/20 | 0.42 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.40 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.39 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11752123 | 0.93 | DRD2 (0.50) | RORARORCRORBPGRDRD2 | |
| SCHEMBL12374352 | 0.86 | RORA (0.69) | RORARORCRORBPGRTLR8 | |
| SCHEMBL12593203 | 0.81 | RORA (0.63) | RORARORCRORBPGRTLR8 | |
| SCHEMBL15396934 | 0.80 | RORA (0.61) | RORARORCRORBPGRTLR8 | |
| SCHEMBL12593202 | 0.80 | RORA (0.61) | RORARORCRORBPGRTLR8 | |
| SCHEMBL14261677 | 0.80 | RORA (0.61) | RORARORCRORBPGRTLR8 | |
| SCHEMBL18055752 | 0.80 | ALDH1A1 (0.47) | MEN1KMT2AALDH1A1CYP2A6 | |
| SCHEMBL12284774 | 0.80 | RORA (0.61) | RORARORCRORBPGRTLR8 | |
| SCHEMBL13503151 | 0.80 | RORA (0.61) | RORARORCRORBPGRTLR8 | |
| SCHEMBL804880 | 0.80 | RORA (0.61) | RORARORCRORBPGRTLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10759802-B2 | Compound, preparation method thereof and organic light emitting display device | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2020-09-01 | — | — | US | disclosed |
| US-20180099968-A1 | COMPOUND, PREPARATION METHOD THEREOF AND ORGANIC LIGHT EMITTING DISPLAY DEVICE | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2018-04-12 | — | — | US | disclosed |
| US-20180099968-A1 | COMPOUND, PREPARATION METHOD THEREOF AND ORGANIC LIGHT EMITTING DISPLAY DEVICE | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2018-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10759802-B2 | Compound, preparation method thereof and organic light emitting display device | OCIAD1, OCIAD2, AOX1 | RORA 298/4885RORC 549/4885RORB 271/4885 |
| US-20180099968-A1 | COMPOUND, PREPARATION METHOD THEREOF AND ORGANIC LIGHT EMITTING DISPLAY DEVICE | OCIAD1, OCIAD2, AOX1 | RORA 298/4885RORC 549/4885RORB 271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.